SCHEMBL30005891

SCHEMBL30005891

CCS(=O)(=O)n1ccc2c(-c3c(C)c4c(c5c3OCC5)NC(C)(C)c3nnc(C)n3-4)cccc21

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23647822 1.00 — —
SCHEMBL23648070 0.93 — —
SCHEMBL30006026 0.93 HTR6 (0.31) —
SCHEMBL23647832 0.93 HTR6 (0.31) —
SCHEMBL30005800 0.91 — —
SCHEMBL30006101 0.91 HTR6 (0.32) —
SCHEMBL23647803 0.91 HTR6 (0.32) —
SCHEMBL23647839 0.91 — —
SCHEMBL23658813 0.84 — —
SCHEMBL23647886 0.84 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4090660-A1 QUINOXALINE DERIVATIVES Grünenthal GmbH (DE) 2022-11-23 — — EP claimed
EP-4090660-A1 QUINOXALINE DERIVATIVES Grünenthal GmbH (DE) 2022-11-23 — — EP disclosed
Send feedback